Status:
ENROLLING_BY_INVITATION
Collaborative Approach to Reach Everyone With Familial Hypercholesterolemia (CARE-FH)
Lead Sponsor:
Geisinger Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Familial Hypercholesterolemia
Eligibility:
All Genders
26+ years
Phase:
NA
Brief Summary
Diagnosis rates of familial hypercholesterolemia (FH) are low in the United States, despite multiple guidelines and recommendations for screening and treatment of high cholesterol, to prevent heart at...
Detailed Description
Familial hypercholesterolemia (FH) is a common genetic disorder (prevalence 1 in 250) that requires lifelong sustained medical care. Evidence-based guidelines for screening and treatment for FH exist....
Eligibility Criteria
Inclusion
- Primary care clinicians (pediatrician, community medicine, internal medicine) in the Geisinger Healthcare System
Exclusion
- None
Key Trial Info
Start Date :
September 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
532 Patients enrolled
Trial Details
Trial ID
NCT05284513
Start Date
September 9 2022
End Date
January 1 2027
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Clinic
Multiple Locations, Pennsylvania, United States, 00000